Literature DB >> 137414

Characteristics of tetrahydrocannabinol (THC)-produced discrimination in rats.

T U Järbe, J O Johansson, B G Henriksson.   

Abstract

UNLABELLED: Rats were trained in a T-shaped maze to discriminate the effects produced by i.p. injections of tetrahydrocannabinol (THC) and the no-drug state (state-dependency, StD). Several doses of both Delta8-THC (range: 0.75-5.0 mg/kg) and Delta9-THC (range: 0.75-40.0 mg/kg) were used in order to compare the number of sessions required by the animals until reaching criterion performance. An additional group of rats had to discriminate pentobarbital sodium (20.0 mg/kg) from the no-drug state.
RESULTS: THC discrimination was proportional to dose i.e., animals that had to differentiate high doses of THC from no drug acquired the T-maze task faster than animals trained with the lower doses of THC. Acquisition data further suggest that Delta8-THC is somewhat less potent than the Delta9-isomer. Delta9-THC (10.0 mg/kg) produces strong StD, as defined by Overton (1971), since both this group and the barbiturate group reached the criterion within the first 10 training sessions. Time and dose testings suggest that stimulus properties of drugs vary in a quantitative way and that the calculated ED50 values are mainly determined by the training dose used. It was found that the higher the training dose used the higher was the corresponding ED50 value. Hashish smoke can maintain drug responding among THC-trained rats. A lowered content of brain catecholamines and/or serotonin, induced by AMPT (150 mg/kg) and PCPA (310-350 mg/kg), did not lessen Delta9-THC (2.5 mg/kg) discrimination.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 137414     DOI: 10.1007/bf00423258

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  Cannabis-induced vocalization in the rat.

Authors:  B G Henriksson; T Järbe
Journal:  J Pharm Pharmacol       Date:  1971-06       Impact factor: 3.765

2.  Studies on the time course and the effect of cholinergic and adrenergic receptor blockers on the stimulus effect of nicotine.

Authors:  I D Hirschhorn; J A Rosecrans
Journal:  Psychopharmacologia       Date:  1974

3.  Aggressive behaviour elicited in rats by Cannabis sativa: effects of p-chlorophenylalanine and DOPA.

Authors:  J Palermo Neto; E A Carlini
Journal:  Eur J Pharmacol       Date:  1972-02       Impact factor: 4.432

4.  Interactions in man of delta-9-tetrachydrocannabinol. 1. Alphamethylparatyrosine.

Authors:  L E Hollister
Journal:  Clin Pharmacol Ther       Date:  1974-01       Impact factor: 6.875

5.  Influence of alpha-methyltyrosine on enhancement of shuttle-box avoidance by marijuana and pentobarbital.

Authors:  J H Pirch; K C Osterholm
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1974-06

6.  Dissociation between behavioral effects and changes in metabolism of cerebral serotonin following 9 -tetrahydrocannabinol.

Authors:  D W Gallager; E Sanders-Bush; F Sulser
Journal:  Psychopharmacologia       Date:  1972

7.  1 - and 1 ( 6 ) tetrahydrocannabinol: preliminary observations on similarities and differences in central pharmacological effects in the cat.

Authors:  M Segal; A F Kenney
Journal:  Experientia       Date:  1972-07-15

8.  Drug discrimination in rats: the effects of phencyclidine and ditran.

Authors:  T U Järbe; J O Johansson; B G Henriksson
Journal:  Psychopharmacologia       Date:  1975-04-30

9.  Discriminative response control produced with hashish, tetrahydrocannabinols (delta 8-THC and delta 9-THC), and other drugs.

Authors:  T U Järbe; B G Henriksson
Journal:  Psychopharmacologia       Date:  1974

10.  Activity of delta8- and delta9-tetrahydrocannabinol and related compounds in the mouse.

Authors:  H D Christensen; R I Freudenthal; J T Gidley; R Rosenfeld; G Boegli; L Testino; D R Brine; C G Pitt; M E Wall
Journal:  Science       Date:  1971-04-09       Impact factor: 47.728

View more
  13 in total

Review 1.  Meta-analysis of cannabinoid ligand binding affinity and receptor distribution: interspecies differences.

Authors:  J M McPartland; M Glass; R G Pertwee
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

Review 2.  "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Authors:  Torbjörn U C Järbe; Roger S Gifford
Journal:  Life Sci       Date:  2013-07-25       Impact factor: 5.037

3.  Stimulus effects of delta(9)-THC and its interaction with naltrexone and catecholamine blockers in rats.

Authors:  T U Järbe; G C Ohlin
Journal:  Psychopharmacology (Berl)       Date:  1977-10-20       Impact factor: 4.530

4.  A comparison of testing procedures on the discriminative morphine stimulus.

Authors:  G L Kaempf; M J Kallman
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Conditioning of an interoceptive drug stimulus to different exteroceptive contexts.

Authors:  T U Järbe; U Sterner; C Hjerpe
Journal:  Psychopharmacology (Berl)       Date:  1981       Impact factor: 4.530

6.  Discriminative properties of pentobarbital after repeated noncontingent exposure in gerbils.

Authors:  T U Järbe; B Holmgren
Journal:  Psychopharmacology (Berl)       Date:  1977-06-06       Impact factor: 4.530

7.  Comparison of the degree of discriminability of various drugs using the T-maze drug discrimination paradigm.

Authors:  D A Overton
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Morphine as a discriminative cue in gerbils: drug generalization and antagonism.

Authors:  T U Järbe; C Rollenhagen
Journal:  Psychopharmacology (Berl)       Date:  1978-07-19       Impact factor: 4.530

9.  Cocaine as a discriminative cue in rats: interactions with neuroleptics and other drugs.

Authors:  T U Järbe
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

10.  delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111.

Authors:  T U Järbe; D E McMillan
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.